[Federal Register Volume 86, Number 138 (Thursday, July 22, 2021)]
[Notices]
[Page 38729]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15557]



[[Page 38729]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; National Institute Of Allergy And 
Infectious Diseases (NIAID) Clinical Site Monitoring Center (CSMC).
    Date: August 17, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G53, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Konrad Krzewski, Ph.D., Scientific Review 
Officer, Scientific Review Program, National Institute of Allergy 
and Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 3G53, Rockville, MD 20852, 240-747-7526, 
<a href="/cdn-cgi/l/email-protection#670c0809150603490c151d0210140c0e27090e0f49000811"><span class="__cf_email__" data-cfemail="23484c4d5142470d485159465450484a634d4a4b0d444c55">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID 2021 DMID Omnibus BAA (HHS-
NIH-NIAID-BAA2021-01) Research Area 002: Development of Therapeutic 
Products for Biodefense, Anti-Microbial Resistant (AMR) Infections 
and Emerging Infectious Diseases-Viral Therapeutics.
    Date: August 18-19, 2021.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G53, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Frank S. De Silva, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G53, 
Rockville, MD 20892-9823, (240) 669-5023, <a href="/cdn-cgi/l/email-protection#94f2f0f1e7fdf8e2f5d4fafdf5fdf0bafafdfcbaf3fbe2"><span class="__cf_email__" data-cfemail="492f2d2c3a20253f2809272028202d67272021672e263f">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 16, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-15557 Filed 7-21-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>